Windtree (WINT) falls 2.15% on Moderate Volume September 14

Equities Staff  |

Today, Windtree Therapeutics Inc Inc’s (NASDAQ: WINT) stock fell $0.04, accounting for a 2.15% decrease. Windtree opened at $1.88 before trading between $1.88 and $1.80 throughout Tuesday’s session. The activity saw Windtree’s market cap fall to $48,602,110 on 86,064 shares -below their 30-day average of 243,307.

About Windtree Therapeutics Inc

Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with lead candidate istaroxime being developed as a first-in-class treatment for acute heart failure and early cardiogenic shock in heart failure. Windtree has also focused on developing AEROSURF® as a non-invasive surfactant treatment for premature infants with respiratory distress syndrome, and is facilitating transfer of clinical development of AEROSURF® to its licensee in Asia, Lee's HK, while Windtree evaluates other uses for its synthetic KL4 surfactant for the treatment of acute pulmonary conditions including lung injury due to viral, chemical and radiation induced insults. Also, in its portfolio is rostafuroxin, a novel precision drug product targeting hypertensive patients with certain genetic profiles.

Visit Windtree Therapeutics Inc's profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Windtree Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Windtree Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

FAA Urges Airlines To Take Stronger Action With Unruly, Disruptive Passengers
Freshworks Leaps 32% on First Day of Trading After Pricing Above Filing Range
Twitter Settles Class Action for $809.5 Million Over Providing Misleading Information to Investors
DoorDash Adds Alcohol Delivery in 20 US States, DC, Canada, Australia
Bill Gates Raises More Than $1 Billion for Clean Energy Technology
CVS Health To Hire 25,000 in Virtual Career Event Friday September 24
President Biden's New Alliance With Australia and Britain Angers France and European Union
California Governor Newsom Signs Affordable Housing Law



Market Movers

Sponsored Financial Content